Sandoz Opens Up The Market For Its US Remodulin Rival
Subcutaneous Version Of Treprostinil Approved For Existing Device More Than Doubles Opportunity
Sandoz has broadened the opportunity that is open to its generic treprostinil, which is now available for subcutaneous use in the US after the FDA approved a new cartridge for use with the Smiths Medical pump that was previously only able to use branded Remodulin.
